Drug Regulation

Public Health Congressional Oversight NHS Guidelines Pharmaceutical Supply FDA Patent Laws Public Safety Access to Treatment Pharmaceutical Patents Price Control FDA Approval Pricing Policies Anesthesia Practices Pharmaceutical Access Medical Oversight International Trade Patent Law Pharmaceutical Industry

10 ARTICLES

4mo ago

Supreme Court Clears Path for Generic 'Skinny Labels' in Unanimous Hikma Ruling

The court said routine FDA-compliant labels and ordinary marketing do not by themselves prove inducement and set a higher bar requiring clear affirmative steps to encourage patented uses.